As of publication, nearly 2,000 Kaiser Permanente mental health workers still had to ratify the vote, and would participate in a two-day process to do so.
Solv has added direct real-time booking to Solv Connect, its marketplace for same-day and next-day healthcare appointments. This announcement decouples Solv Connect from the company's other software offering, Solv Experience, which is its practice management platform. The first customer the company is announcing for its new-and-improved Solv Connect offering is Carbon Health, a network of primary care and urgent care clinics.
By Stephanie Baum Thursday, October 20, 2022 6:00 AM
As hospitals face consolidation and CIOs are asked to increase staff productivity, tech companies that can support automation with solutions that are easy to onboard are getting heightened interest.
By Frank Vinluan Wednesday, October 19, 2022 6:33 PM
Novavax's Covid-19 vaccine is now authorized as a booster shot for adults. The regulatory decision, which comes three months after the shot was first granted FDA emergency authorization, introduces a booster shot alternative to messenger RNA vaccines.
By Katie Adams Wednesday, October 19, 2022 5:26 PM
Prenuvo — a company that makes an MRI machine that performs quick whole-body scans — closed a $70 million Series A equity and debt funding round. It will use the money to open more clinics throughout the country, as well as find ways to make its price point more accessible.
By Marissa Plescia Wednesday, October 19, 2022 3:02 PM
Through the new collaboration, Carrum Health is offering GRAIL's cancer test called Galleri as a benefit option for employers. It is an early-detection test for more than 50 types of cancer.
By Jason Povio Wednesday, October 19, 2022 2:00 PM
The pandemic placed an unfathomable burden on the country's doctors. For years to come, we'll be dissecting its implications. Here are six ways healthcare providers can lighten the physician's burden.
By Frank Vinluan Wednesday, October 19, 2022 1:11 PM
Jazz Pharmaceuticals is paying Zymeworks $50 million up front for rights to develop zanidatamab, a bispecific antibody cancer currently in two pivotal clinical trials. It's the second bispecific antibody pact of the week, following Gilead Sciences' deal to secure an option on a MacroGenics drug in early clinical development.
By Katie Adams Wednesday, October 19, 2022 11:18 AM
Ochsner Health recently released the results of its digital health pilot program for Medicaid patients with hypertension and type 2 diabetes. The program, which combines remote patient monitoring with personalized care teams, did an efficient job at bringing down patients' blood pressure and hemoglobin A1c levels.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments